| Dr Tyrus Michael White Jr, MD | |
|
1 Trillium Way, Baptist Health Cancer Center, Corbin, KY 40701-8727 | |
| (606) 523-1934 | |
| (606) 523-1982 |
| Full Name | Dr Tyrus Michael White Jr |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 18 Years |
| Location | 1 Trillium Way, Corbin, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124281167 | NPI | - | NPPES |
| 7100160280 | Medicaid | KY | |
| P01428671 | Other | KY | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 42601 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Corbin | Corbin, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
When the body encounters an infection, a molecular signaling system ramps up the body's infection-fighting system to produce more white blood cells to attack invading bacteria.
A research team at the Wyss Institute for Biologically Inspired Engineering at Harvard University leveraged its organ-on-a-chip technology to develop a model of the human small airway in which lung inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), the third leading cause of mortality worldwide, and asthma can be studied outside the human body.
Temasek Life Science Ventures Pte Ltd and Emergent BioSolutions Inc. today announced their agreement to form EPIC BIO Pte Ltd, a joint venture to develop, manufacture, and commercialize a multivalent, cross-protective human vaccine to protect against influenza caused by a broad range of circulating H5 influenza strains.
In a report published in The Lancet, researchers say there is the potential to develop 20 new or improved vaccines over the next decade. They emphasize that funding is crucial - but so is trust and confidence in vaccines. It is said that AIDS and malaria vaccines as the most important areas for research. Authors further suggest that neglected tropical diseases, such as leprosy, should also be investigated.
After nearly 400 confirmed infections and 100 deaths, the spread of Lassa fever in Nigeria is beginning to slow but the epidemic is far from contained, the World Health Organization and the Nigeria Centre for Disease Control have warned.
› Verified 2 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518360296 PECOS PAC ID: 5597867184 Enrollment ID: O20150206000249 |
News Archive
When the body encounters an infection, a molecular signaling system ramps up the body's infection-fighting system to produce more white blood cells to attack invading bacteria.
A research team at the Wyss Institute for Biologically Inspired Engineering at Harvard University leveraged its organ-on-a-chip technology to develop a model of the human small airway in which lung inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), the third leading cause of mortality worldwide, and asthma can be studied outside the human body.
Temasek Life Science Ventures Pte Ltd and Emergent BioSolutions Inc. today announced their agreement to form EPIC BIO Pte Ltd, a joint venture to develop, manufacture, and commercialize a multivalent, cross-protective human vaccine to protect against influenza caused by a broad range of circulating H5 influenza strains.
In a report published in The Lancet, researchers say there is the potential to develop 20 new or improved vaccines over the next decade. They emphasize that funding is crucial - but so is trust and confidence in vaccines. It is said that AIDS and malaria vaccines as the most important areas for research. Authors further suggest that neglected tropical diseases, such as leprosy, should also be investigated.
After nearly 400 confirmed infections and 100 deaths, the spread of Lassa fever in Nigeria is beginning to slow but the epidemic is far from contained, the World Health Organization and the Nigeria Centre for Disease Control have warned.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tyrus Michael White Jr, MD 5200 Commerce Crossings Dr Fl Floor, Louisville, KY 40229-2182 Ph: (502) 253-4924 | Dr Tyrus Michael White Jr, MD 1 Trillium Way, Baptist Health Cancer Center, Corbin, KY 40701-8727 Ph: (606) 523-1934 |
News Archive
When the body encounters an infection, a molecular signaling system ramps up the body's infection-fighting system to produce more white blood cells to attack invading bacteria.
A research team at the Wyss Institute for Biologically Inspired Engineering at Harvard University leveraged its organ-on-a-chip technology to develop a model of the human small airway in which lung inflammatory diseases, such as chronic obstructive pulmonary disease (COPD), the third leading cause of mortality worldwide, and asthma can be studied outside the human body.
Temasek Life Science Ventures Pte Ltd and Emergent BioSolutions Inc. today announced their agreement to form EPIC BIO Pte Ltd, a joint venture to develop, manufacture, and commercialize a multivalent, cross-protective human vaccine to protect against influenza caused by a broad range of circulating H5 influenza strains.
In a report published in The Lancet, researchers say there is the potential to develop 20 new or improved vaccines over the next decade. They emphasize that funding is crucial - but so is trust and confidence in vaccines. It is said that AIDS and malaria vaccines as the most important areas for research. Authors further suggest that neglected tropical diseases, such as leprosy, should also be investigated.
After nearly 400 confirmed infections and 100 deaths, the spread of Lassa fever in Nigeria is beginning to slow but the epidemic is far from contained, the World Health Organization and the Nigeria Centre for Disease Control have warned.
› Verified 2 days ago
Dr. Swati Yalamanchi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Trillium Way, Baptist Health Cancer Center, Corbin, KY 40701 Phone: 606-523-1934 Fax: 606-523-1982 | |
Dr. Daniel W Whitley, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1419 Cumberland Falls Hwy, Corbin, KY 40701 Phone: 606-528-4481 Fax: 606-528-2857 | |
Dr. John P. Loventhal, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 45 Moonbow Plz, Corbin, KY 40701 Phone: 606-523-9010 Fax: 606-528-0028 | |
Dr. Pramod A Reddy, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 45 Moonbow Plz, Corbin, KY 40701 Phone: 606-523-9010 Fax: 606-523-5923 | |
Priyanka Srinivas, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2 Trillium Way Ste 306, Corbin, KY 40701 Phone: 606-526-4070 Fax: 606-526-4072 | |
Mr. William R Durham, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 513 18th St, Corbin, KY 40701 Phone: 606-526-9664 Fax: 606-526-6263 | |
Jeremy Swiney, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Trillium Way, Corbin, KY 40701 Phone: 606-528-1212 |